Working… Menu

Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer (EECLC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02729493
Recruitment Status : Unknown
Verified March 2017 by Sinobioway Cell Therapy Co., Ltd..
Recruitment status was:  Recruiting
First Posted : April 6, 2016
Last Update Posted : March 15, 2017
Information provided by (Responsible Party):
Sinobioway Cell Therapy Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2019